TrialInternational journal of oncology2015

Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes.

Yu Sawada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.